Skip to main content

Table 1 Patient’s treatment after metastasis

From: Goserelin plus endocrine treatments maintained long-term clinical benefit in a male patient with advanced breast cancer

Treatment line

Start and stop time, year/month

Sites of metastasis

Therapeutic schedule

Best efficacy

TTP

1st

2008/8 to 2008/10

Bone

Docetaxel + cisplatin

SD

TTP = 2 months

2nd

2008/10 to 2008/12

Bone

Docetaxel + capecitabine

SD

TTP = 4 months

3rd

2009/3 to 2009/10

Bone

Letrozole

SD

TTP = 7 months

4th

2009/10 to 2010/10

Bone,lung

Goserelin + anastrozole

SD

TTP = 12 months

5th

2010/10 to 2011/9

Bone,lung

Goserelin + exemestane

SD

TTP = 11 months

6th

2011/9 to 2012/7

Bone,lung

Medroxyprogesterone

SD

TTP = 10 months

7th

2012/8 to 2013/2

Bone,lung

Goserelin + fulvestrant

SD

6+ months

  1. SD stable disease, TTP time to progression.